Table 5:
OxyContin Misuse and Changes in Synthetic Opioid Death Rates
| Outcome: | Overdose Deaths per 100,000 |
|||||
|---|---|---|---|---|---|---|
| (1) | (2) | (3) | (4) | (5) | (6) | |
| A. Synthetic Opioid Deaths per 100,000 (T40.4) | ||||||
| Initial OxyContin (3 Year Effect) | 0.454 (0.405) | 0.616* (0.366) | 0.641* (0.349) | 0.869* (0.444) | 1.137*** (0.262) | 1.223*** (0.339) |
| Initial Pain Reliever (3 Year Effect) | −0.106 (0.108) | −0.085 (0.082) | ||||
| Mean of Dep. Variable (2008–09): | 0.887 | |||||
| B. Synthetic Opioid-Only Deaths per 100,000 (T40.4, but not also T40.1, T40.2, or T40.3) | ||||||
| Initial OxyContin (3 Year Effect) | 0.124 (0.257) | 0.245 (0.223) | 0.267 (0.214) | 0.363 (0.243) | 0.933*** (0.234) | 0.944*** (0.240) |
| Initial Pain Reliever (3 Year Effect) | −0.044 (0.063) | −0.023 (0.066) | ||||
| Mean of Dep. Variable (2008–09): | 0.624 | |||||
| State and Time-Varying Covariates | No | Yes | Yes | Yes | Yes | Yes |
| Policy Variables | No | No | Yes | Yes | Yes | Yes |
| Estimator | OLS | OLS | OLS | OLS | Poisson | Poisson |
Notes: Standard errors in parentheses adjusted for clustering at the state-level. State fixed effects and year fixed effects included in all specifications. Each model also includes a linear trend interacted with initial nonmedical OxyContin misuse as well as a post-2011 indicator interacted with initial nonmedical OxyContin misuse. Finally, a separate post-2011 linear trend interacted with initial nonmedical OxyContin misuse is also included. We report the 3 year post-2011 effect of the initial OxyContin variable. Regressions are weighted by population. Years 2008–2013 are used.
Significant at the 1% level
Significant at the 5% level
Significant at the 10% level.